Article Text

PDF
Terbutaline: level the playing field for inhaled β2-agonists by introducing a dosing and urine threshold
  1. Glenn A Jacobson1,
  2. Morten Hostrup2,3
  1. 1 School of Medicine, University of Tasmania, Hobart, Tasmania, Australia
  2. 2 Section of Integrative Physiology, Department of Nutrition Exercise and Sports, University of Copenhagen, Copenhagen, Denmark
  3. 3 Department of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen, Denmark
  1. Correspondence to Dr Glenn A Jacobson, School of Medicine, Private Bag 26, Hobart, Tasmania 7001, Australia; glenn.jacobson{at}utas.edu.au

Abstract

Terbutaline, a short-acting β2-agonist similar to salbutamol, is widely used in Europe in the treatment of asthma and exercise-induced bronchoconstriction. Unlike salbutamol, terbutaline requires therapeutic use exemption (TUE) for therapeutic inhaled use in competitive sport. There is now compelling evidence that supratherapeutic use of terbutaline is performance enhancing, via oral dosing and inhalation. It is likely that the ergogenic effects of terbutaline are class specific for all β2-agonists. The World Anti-Doping Agency (WADA) has introduced dosing and urine threshold and decision limits for other common β2-agonists. This allows athletes to use these drugs for therapeutic purposes while minimising the potential for doping and administrative burden of TUEs. However, no such threshold limits currently exist for terbutaline. For terbutaline, athletes can be granted a TUE, then administer the drug via inhalation at supratherapeutic doses with impunity. The introduction of threshold dosing and urine limits for terbutaline should be a high priority, given the drug's demonstrated ergogenic effects.

  • Asthma
  • Pulmonary
  • Respiratory
  • Doping

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.